PT. Daewoong Infion clinical trials
A country office of Daewoong Pharmaceutical Co. LTD.
The registry lists 3 studies whose lead sponsor is PT. Daewoong Infion. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 22, 2022.
Registry sponsor names on this page
- PT. Daewoong Infion3 studies
Something wrong with this grouping? Tell us on the Daewoong Pharmaceutical Co. LTD. page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Daewoong Pharmaceutical Co. LTD. studies →
- Efficacy and Safety Evaluation of EASYEF® in Acute Wound (Split-thickness Skin Graft Donor Site)CompletedNCT05335720Not applicable
Sponsor listed in the registry: PT. Daewoong Infion
- The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD PatientsCompletedNCT05422755
Sponsor listed in the registry: PT. Daewoong Infion
- The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®CompletedNCT05373303Not applicable
Sponsor listed in the registry: PT. Daewoong Infion